Drug intelligence / Profile preview

18F-C27

Development stage
Unknown
Lead developer
National University of Singapore
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

18F-C27 is a fluorine-18 (18F) radiolabeled small-molecule fibroblast activation protein (FAP) inhibitor developed for positron emission tomography (PET) imaging. It consists of the small-molecule FAP inhibitor C27 conjugated to a NOTA chelator and radiolabeled with fluorine-18. FAP is highly and selectively expressed in the stroma of various epithelial cancers, particularly on cancer-associated fibroblasts (CAFs), while showing minimal expression in normal tissues. 18F-C27 PET/CT imaging is being evaluated as a diagnostic tool for the detection, staging, and monitoring of solid tumors, such as lung cancer, demonstrating high accuracy and specificity in identifying primary lesions and metastases compared to 18F-FDG.

Other names
[18F]-C27[18F]C2718F-labeled C27F-18-C27F18-C27F 18-C27
02

Targets

FAP (Fibroblast activation protein alpha)

Beyond the preview

Go deeper on 18F-C27.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-C27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call